DNA vaccine protection against SARS-CoV-2 in rhesus macaques
…, F Nampanya, R Nityanandam, JD Ventura, H Wan… - Science, 2020 - science.org
The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
[HTML][HTML] Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
…, JP Nkolola, S Patel, JD Ventura, K Verrington, H Wan… - Nature, 2020 - nature.com
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
[HTML][HTML] Neutralization of the SARS-CoV-2 Omicron BA. 1 and BA. 2 variants
…, M Rowe, F Mardas, JD Ventura, H Wan… - … England Journal of …, 2022 - Mass Medical Soc
Neutralization of Omicron BA.1 and BA.2 Variants Although two doses of BNT162b2 vaccine
produce immunity that wanes over time, the administration of a booster dose substantially …
produce immunity that wanes over time, the administration of a booster dose substantially …
Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women
Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
[HTML][HTML] Differential kinetics of immune responses elicited by Covid-19 vaccines
…, O Powers, EA Bondzie, H Wan… - … England Journal of …, 2021 - Mass Medical Soc
Kinetics of Immune Response to Covid-19 Vaccines B-cell and T-cell responses were
measured to assess the stability and duration of vaccine-induced immunity. Responses to …
measured to assess the stability and duration of vaccine-induced immunity. Responses to …
[PDF][PDF] Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
The rapid spread of the SARS-CoV-2 Omicron (B.1.1.529) variant, including in highly
vaccinated populations, has raised important questions about the efficacy of current vaccines. In …
vaccinated populations, has raised important questions about the efficacy of current vaccines. In …
Deletion of the SARS-CoV-2 spike cytoplasmic tail increases infectivity in pseudovirus neutralization assays
Pseudotyped viruses are valuable tools for studying virulent or lethal viral pathogens that
need to be handled in biosafety level 3 (BSL3) or higher facilities. With the explosive spread of …
need to be handled in biosafety level 3 (BSL3) or higher facilities. With the explosive spread of …
[HTML][HTML] Protective efficacy of Ad26. COV2. S against SARS-CoV-2 B. 1.351 in macaques
The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses
a threat to the efficacy of current COVID-19 vaccines 1 , 2 . The Ad26.COV2.S vaccine …
a threat to the efficacy of current COVID-19 vaccines 1 , 2 . The Ad26.COV2.S vaccine …
Immunity elicited by natural infection or Ad26. COV2. S vaccination protects hamsters against SARS-CoV-2 variants of concern
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have
emerged and may pose a threat to both the efficacy of vaccines based on the original WA1/…
emerged and may pose a threat to both the efficacy of vaccines based on the original WA1/…
Correlates of neutralization against SARS-CoV-2 variants of concern by early pandemic sera
Emerging SARS-CoV-2 variants of concern that overcome natural and vaccine-induced
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests that …
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests that …